The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vashkevich A.A.

North-Western State Medical University named after I.I. Mechnikov

Suvorova A.A.

North-Western State Medical University named after I.I. Mechnikov

Raznatovsky K.I.

North-Western State Medical University named after I.I. Mechnikov

Reztsova P.A.

North-Western State Medical University named after I.I. Mechnikov

Gulordava M.D.

North-Western State Medical University named after I.I. Mechnikov

Levina Yu.V.

Pirogov Russian National Research Medical University;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

Perioral dermatitis: new approaches to therapy

Authors:

Vashkevich A.A., Suvorova A.A., Raznatovsky K.I., Reztsova P.A., Gulordava M.D., Levina Yu.V.

More about the authors

Read: 71198 times


To cite this article:

Vashkevich AA, Suvorova AA, Raznatovsky KI, Reztsova PA, Gulordava MD, Levina YuV. Perioral dermatitis: new approaches to therapy. Russian Journal of Clinical Dermatology and Venereology. 2023;22(1):49‑56. (In Russ.)
https://doi.org/10.17116/klinderma20232201149

Recommended articles:
Clinical case: Hailey-Hailey disease or Darier’s disease?. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):537-541
Hidradenitis suppurativa: a clinical case. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):542-545
Pigmented Form of Bowen’s Disease. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):667-672
Clinical Case of HIV-Associated Kaposi’s Sarcoma. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):782-786
Dissecting cellulitis of the scalp (Hoffman’s disease): a clinical case. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):45-48
Specifics of cancer dete­ction at the outpatient stage. A case report. Russian Journal of Preventive Medi­cine. 2024;(10):97-100
Psychopathological diso­rders at the onset of juve­nile parkinsonism in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):96-102
Giant peri­cranial sinus with exte­nsive occi­pital calvarium defect. Burdenko's Journal of Neurosurgery. 2024;(6):77-87
Vagi­nal yolk sac tumour in a newborn. Russian Journal of Human Reproduction. 2024;(6):132-139
Features of differential diagnosis of onco­logical pathology at the outpatient stage. Russian Journal of Preventive Medi­cine. 2025;(2):93-95

References:

  1. Mihan R, Ayres S. Perioral dermatitis. Arch Dermatol. 1964;89:803-805.  https://doi.org/10.1001/archderm.1964.01590300031010
  2. Zeba HH. Perioral dermatitis: an update. Int J Dermatol. 2003;42:515-517.  https://doi.org/10.1046/j.1365-4362.2003.01852.x
  3. Williams HC, Ashworth J, Pembroke AC, Breathnach SM. FACE — facial Afro-Caribbean childhood eruption. Clin Exp Dermatol. 1990;15:163-166. 
  4. Hameed AF. Clinical Study Steroid Dermatitis Resembling Rosacea: A Clinical Evaluation of 75 Patients. ISRN Dermatology. 2013;4.  https://doi.org/10.1155/2013/491376
  5. Clementson B, Smidt AC. Periorificial dermatitis due to systemic corticosteroids in children: report of two cases. Pediatr Dermatol. 2012;29:331.  https://doi.org/10.1111/j.1525-1470.2011.01651.x
  6. Peralta L, Morais P. Perioral dermatitis — the role of nasal steroids. Cutan Ocul Toxicol. 2012;31:160.  https://doi.org/10.3109/15569527.2011.621918
  7. Novozhilova OL. Steroid rosacea caused by inhaled glucocorticosteroid agents. Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, 2015. https://doi.org/10.17116/klinderma201514666-68
  8. Ljubojeviæ S. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. JEADV. 2002;16:121-126.  https://doi.org/10.1046/j.1468-3083.2002.00388_2.x
  9. Erbagci Z, Ozgaztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol. 1998;37:421-425.  https://doi.org/10.1046/j.1365-4362.1998.00218.x
  10. Leyden SJ, Thew M, Kligman AM. Steroid rosacea. Arch Dermatol. 1974; 110:619-622.  https://doi.org/10.1001/archderm.110.4.619
  11. Zhneg P, Lovker RM, Lehmann P, Kligman AM. Morphologic investigation on the rebound phenomenon after corticosteroidinduced atrophy in human skin. J Invest Dermatol. 1984;82:345-352.  https://doi.org/10.1111/1523-1747.ep12260665
  12. Sneddon I. Adverse effect of topical fluorinated corticosteroids in rosacea. Br Med J. 1969;1:671-673.  https://doi.org/10.1136/bmj.1.5645.670
  13. Buck A. Zum Nachweis von Fusobakterien aus Effloreszenzen der perioralen Dermatitis. DMW. 1971;22:433-436.  https://doi.org/10.1055/s-0028-1107766
  14. Berardi P. Demonstration of fusobacteria in eruptions of perioral dermatitis using the tape stripping toluidine blue method. J Eur Acad Dermatol Venereol. 1994;3(4):495-499.  https://doi.org/10.1111/j.1468-3083.1994.tb00407.x
  15. Adaskevich UP, Miadzelets MO. The possible role of fusiform bacteria in the etiopathogenesis of perioral dermatitis. Vestnik VGMU. 2019;18(3):75-80.  https://doi.org/10.22263/2312-4156.2019.3.75
  16. Erbagci Z, Ozgaztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol. 1998;37:421-425. 
  17. Reznichenko NYu, Golovkin AV. Perioral dermatitis. Features of diagnosis and treatment. Journal of Dermatovenereology and Cosmetology named after M.O. Torsueva. 2017;1:37. (In Russ.).
  18. Plewig G. Periorale Dermatitis. In Braun-Falco O PG, Wolff HH, Burgdorf WHC, Landthaler M eds. Dermatologie und Venerologie. Heidelberg: Springer. 2005;907-909.  https://doi.org/10.1007/978-3-642-57960-8_41
  19. Zrinka Bukvić Mokos perioral dermatitis: still a therapeutic challenge. Acta Clin Croat. 2015;54:179-185. 
  20. Dirschka T, Tronnier H. Periokuläre Dermatitis. J Dtsch Dermatol Ges. 2004;2(4):274-278.  https://doi.org/10.1046/j.1439-0353.2004.04768.x
  21. Dirschka T, Szliska C, Jackowski J, Tronnier H. Impaired skin barrier and atopic diathesis in perioral dermatitis. J Dtsch Dermatol Ges. 2003;1:199-203.  https://doi.org/10.1046/j.1610-0387.2003.02039.x
  22. Fritsch P, Pichler E, Linser I. Periorale Dermatitis. Hautarzt. 1989;40: 475-479. 
  23. Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticoid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol. 2001;7:73-77.  https://doi.org/10.1034/j.1600-0846.2001.70203.x
  24. Pabby A, An KP, Laws RA. Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid-induced periocular rosacea. Cutis. 2003;72:141-142. 
  25. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol. 2001;44:995-998.  https://doi.org/10.1067/mjd.2001.114739
  26. Marks R, Black MM. Perioral dermatitis. A histopathologic study of 26 cases. Br. J. Dermatol. 1971;84(3):242-247. 
  27. Frieden IJ, Prose NS, Fletcher V, Turner ML. Granulomatous perioral dermatitis in children. Arch Dermatol. 1989;125(3):369-373.  https://doi.org/10.1001/archderm.125.3.369
  28. Oppel T, Pavicic T, Kamann S, et al. Pimecrolimus cream (1%. efficacy in perioral dermatitis — results of a randomized, double-blind, vehicle-controlled study in 40 patients. J Eur Acad Dermatol Venereol. 2007;21:1175-1180. https://doi.org/10.1111/j.1468-3083.2007.02191.x
  29. Andreas Wollenberg, Thomas Bieber & Co. Perioral dermatitis. JDDG. 2011 May.  https://doi.org/10.1111/j.1610-0387.2010.07329.x
  30. Weber K, Thurmayr R. Critical appraisal of reports on the treatment of perioral dermatitis. Dermatology. 2005;210:300-307.  https://doi.org/10.1159/000084754
  31. Röckl H, Schubert E. Zur Therapie dersogenannten perioralen Dermatitis. Hautarzt. 1971;22:527-531. 
  32. Schubert E, Beetz HM, Röckl H. Über den Wert der Tetrazyklin-Therapie bei der perioralen Dermatitis. Hautarzt. 1973;24:253. 
  33. Weber K, Thurmayr R, Meisinger A. A topical erythromycin preparation and oral tetracycline for the treatment of perioral dermatitis: A placebocontrolled trial. J Dermatol Treat. 1993;4:57-59.  https://doi.org/10.3109/09546639309084514
  34. Schwarz T, Kreiselmaier I, Bieber T, et al. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. J Am Acad Dermatol. 2008;59:34.  https://doi.org/10.1016/j.jaad.2008.03.043
  35. Oppel T, Pavicic T, Kamann S, et al. Pimecrolimus cream (1%. efficacy in perioral dermatitis — results of a randomized, double-blind, vehicle-controlled study in 40 patients. J Eur Acad Dermatol Venereol. 2007;21:1175. https://doi.org/10.1111/j.1468-3083.2007.02191.x
  36. Rodríguez-Martín M, Sáez-Rodríguez M, Carnerero-Rodríguez A, et al. Treatment of perioral dermatitis with topical pimecrolimus. J Am Acad Dermatol. 2007;56:529.  https://doi.org/10.1016/j.jaad.2005.03.011
  37. Mørtz CG, Deleuran MS. A case of childhood granulomatous perioral dermatitis (CGPD. in a three year old boy from Madagascar. Ugeskr Laeger. 2008;170:352. 
  38. Weber K, Thurmayr R, Meisinger A. A topical erythromycin preparation and oral tetracycline for the treatment of perioral dermatitis: a placebo controlled trial. J Dermatol Treat. 1993;4:57.  https://doi.org/10.3109/09546639309084514
  39. Weber K. How I treat perioral dermatitis: non-compliance with the treatment guidelines. Dermatology. 2003;207:215.  https://doi.org/10.1159/000071804
  40. Veien NK, Munkvad JM, Nielsen AO, Niordson AM, Stahl D, Thormann J. Topical metronidazole in the treatment of perioral dermatitis. J Am Acad Dermatol. 1991;24:258-260.  https://doi.org/10.1016/0190-9622(91.70038-4
  41. Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. J Am Acad Dermatol. 2006;55:781.  https://doi.org/10.1016/j.jaad.2006.05.031
  42. Laude TA, Salvemini JN. Perioral dermatitis in children. Semin Cutan Med Surg. 1999;18:206.  https://doi.org/10.1016/s1085-5629(99.80018-2
  43. Boeck K, Abeck D, Werfel S, Ring J. Perioral dermatitis in children--clinical presentation, pathogenesis-related factors and response to topical metronidazole. Dermatology. 1997;195:235–238.  https://doi.org/10.1159/000245950
  44. Zip CM. Innovative use of topical metronidazole. Dermatol Clin. 2010; 28:525.  https://doi.org/10.1016/j.det.2010.03.015
  45. Jansen T. Azelaic acid as a new treatment for perioral dermatitis: results from an open study. Br J Dermatol. 2004;151:933.  https://doi.org/10.1111/j.1365-2133.2004.06202.x
  46. Jansen T, Melnik BC, Schadendorf D. Steroid-induced periorificial dermatitis in children — clinical features and response to azelaic acid. Pediatr Dermatol. 2010;27:137.  https://doi.org/10.1111/j.1525-1470.2009.00979.x
  47. Coskey RJ. Perioral dermatitis. Cutis. 1984;34:55. 
  48. Richey DF, Hopson B. Photodynamic therapy for perioral dermatitis. J Drugs Dermatol. 2006;5:12. 
  49. Wilson RG. Topical tetracycline in the treatment of perioral dermatitis. Arch Dermatol. 1979;115:637.  https://doi.org/10.1001/archderm.1979.04010050061030
  50. Jansen T. Perioral dermatitis successfully treated with topical adapalene. J Eur Acad Dermatol Venereol. 2002;16:175.  https://doi.org/10.1046/j.1468-3083.2002.00392_4.x
  51. Wilkinson DS, Kirton V, Wilkinson JD. Perioral dermatitis: a 12-year review. Br J Dermatol. 1979;101:245  https://doi.org/10.1111/j.1365-2133.1979.tb05616.x
  52. Weber K, Thurmayr R. Critical appraisal of reports on the treatment of perioral dermatitis. Dermatology. 2005;210:300.  https://doi.org/10.1159/000084754
  53. Macdonald A, Feiwel M. Perioral dermatitis: aetiology and treatment with tetracycline. Br J Dermatol. 1972;87:315.  https://doi.org/10.1111/j.1365-2133.1972.tb07416.x
  54. Miller WS. Tetracycline in the treatment of perioral dermatitis. N C Med J. 1971;32:471. 
  55. Cochran RE, Thomson J. Perioral dermatitis: a reappraisal. Clin Exp Dermatol. 1979;4:75.  https://doi.org/10.1111/j.1365-2230.1979.tb01593.x
  56. Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. J Am Acad Dermatol. 2006;55:781.  https://doi.org/10.1016/j.jaad.2006.05.031
  57. Urbatsch AJ, Frieden I, Williams ML, et al. Extrafacial and generalized granulomatous periorificial dermatitis. Arch Dermatol. 2002;138:1354. https://doi.org/10.1001/archderm.138.10.1354
  58. Coskey RJ. Perioral dermatitis. Cutis. 1984;34:55. 
  59. Choi YL, Lee KJ, Cho HJ, et al. Case of childhood granulomatous periorificial dermatitis in a Korean boy treated by oral erythromycin. J Dermatol. 2006;33:806.  https://doi.org/10.1111/j.1346-8138.2006.00183.x
  60. Weston WL, Morelli JG. Identical twins with perioral dermatitis. Pediatr Dermatol. 1998;15:144.  https://doi.org/10.1111/j.1525-1470.1998.tb01304.x
  61. Henningsen E, Bygum A. Budesonide-induced periorificial dermatitis presenting as chalazion and blepharitis. Pediatr Dermatol. 2011;28:596.  https://doi.org/10.1111/j.1525-1470.2011.01516.x
  62. Smith KW. Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin. Cutis. 1990;46:413. 
  63. Rodriguez-Garijo N, Querol-Cisneros E, Tomas-Velazquez A, et al. Recalcitrant granulomatous periorificial dermatitis with good response to low-dose oral isotretinoin. Pediatr Dermatol. 2019;36:980.  https://doi.org/10.1111/pde.13969
  64. Therdpong Tempark, Tor A. Shwayder, Perioral Dermatitis: A Review of the Condition with Special Attention to Treatment Options. Am J Clin Dermatol. 2014;15:101-113.  https://doi.org/10.1007/s40257-014-0067-7
  65. Noguera-Morel L, Gerlero P, Torrelo A, Hernández-Martín Á. Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases. J Am Acad Dermatol. 2017;76:567.  https://doi.org/10.1016/j.jaad.2016.10.034
  66. Zargari O, Aghazadeh N, Moeineddin F. Clinical applications of topical ivermectin in dermatology. Dermatol Online J. 2016;22:9.  https://doi.org/10.5070/d3229032496
  67. Charnowski S, Wollenberg A, Reinholz M. Perioral Dermatitis Successfully Treated with Topical Ivermectin. Ann Dermatol. 2019;31:27-28.  https://doi.org/10.5021/ad.2019.31.S.S27
  68. Kircik LH, Del Rosso JQ, Layton AM, Schauber J. Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications. J Drugs Dermatol. 2016;15(3):325-332. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.